Gene · 5362
Papers4,083
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 4,083
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Intestinal Microbes in Patients With Schizophrenia Undergoing Short-Term Treatment: Core Species Identification Based on Co-Occurrence Networks and Regression Analysis. | Front Microbiol | 2022 | 35783418 | PubTator, text mining | PubMed |
| Editorial: Perineuronal Nets as Therapeutic Targets for the Treatment of Neuropsychiatric Disorders. | Front Synaptic Neurosci | 2022 | 35782789 | PubTator, text mining | PubMed |
| Changes of retinal ganglion cell complex after vitrectomy in rhegmatogenous retinal detachment patients and its correlation with inflammatory blood biomarkers. | BMC Ophthalmol | 2022 | 35780091 | PubTator, text mining | PubMed |
| Comparative analysis of OCT-defined parapapillary beta and gamma zones between primary open angle glaucoma and primary angle closure glaucoma. | Sci Rep | 2022 | 35773326 | PubTator, text mining | PubMed |
| Switching to ziv-aflibercept in resistant diabetic macular edema non responsive to ranibizumab injection. | BMC Ophthalmol | 2022 | 35768859 | PubTator, text mining | PubMed |
| Chronic relapsing inflammatory optic neuropathy (CRION). | Arq Neuropsiquiatr | 2022 | 35766639 | PubTator, text mining | PubMed |
| Chelerythrine Chloride Inhibits Stemness of Melanoma Cancer Stem-Like Cells (CSCs) Potentially via Inducing Reactive Oxygen Species and Causing Mitochondria Dysfunction. | Comput Math Methods Med | 2022 | 35761835 | PubTator, text mining | PubMed |
| Manufacturing Mesenchymal Stromal Cells for the Treatment of Osteoarthritis in Canine Patients: Challenges and Recommendations. | Front Vet Sci | 2022 | 35754551 | PubTator, text mining | PubMed |
| High Affinity Decynium-22 Binding to Brain Membrane Homogenates and Reduced Dorsal Camouflaging after Acute Exposure to it in Zebrafish. | Front Pharmacol | 2022 | 35754508 | PubTator, text mining | PubMed |
| Risk factors for visual field progression in newly diagnosed exfoliation glaucoma patients in Sweden. | Sci Rep | 2022 | 35750795 | PubTator, text mining | PubMed |
| Flat irregular pigment epithelial detachment over time and outcome of different treatment regimens. | Sci Rep | 2022 | 35750709 | PubTator, text mining | PubMed |
| Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs). | Pharmaceutics | 2022 | 35745806 | PubTator, text mining | PubMed |
| Novel Eye Drop Delivery Systems: Advance on Formulation Design Strategies Targeting Anterior and Posterior Segments of the Eye. | Pharmaceutics | 2022 | 35745723 | PubTator, text mining | PubMed |
| Elucidating macular structure-function correlations in glaucoma. | Sci Rep | 2022 | 35739208 | PubTator, text mining | PubMed |
| Repeatability and Discriminatory Power of Chart-Based Visual Function Tests in Individuals With Age-Related Macular Degeneration: A MACUSTAR Study Report. | JAMA Ophthalmol | 2022 | 35737401 | PubTator, text mining | PubMed |
| HIOP-Reader: Automated Data Extraction for the Analysis of Manually Recorded Nycthemeral IOPs and Glaucoma Progression. | Transl Vis Sci Technol | 2022 | 35737376 | PubTator, text mining | PubMed |
| Macular microcirculation changes after macula-off rhegmatogenous retinal detachment repair with silicone oil tamponade evaluated by OCT-A: preliminary results. | Ther Adv Ophthalmol | 2022 | 35734223 | PubTator, text mining | PubMed |
| Connecting the DOTs on Cell Identity. | Front Cell Dev Biol | 2022 | 35733849 | PubTator, text mining | PubMed |
| Measuring collagen injury depth for burn severity determination using polarization sensitive optical coherence tomography. | Sci Rep | 2022 | 35729262 | PubTator, text mining | PubMed |
| Morphological parameters of myopic choroidal neovascularization as predictive factors of anti-VEGF treatment response. | Sci Rep | 2022 | 35729226 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5362/papers?page=48